Comment on TWO Versus Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial

Simple item page
dc.contributor.authorRomrattaphan R.
dc.contributor.authorDankulchai P.
dc.contributor.authorPrasartseree T.
dc.contributor.authorSittiwong W.
dc.contributor.authorThaweerat W.
dc.contributor.authorJunlabut S.
dc.contributor.authorNitipitch S.
dc.contributor.correspondenceRomrattaphan R.
dc.contributor.otherMahidol University
dc.date.accessioned2026-04-11T18:17:59Z
dc.date.available2026-04-11T18:17:59Z
dc.date.issued2026-05-01
dc.identifier.citationClinical Oncology Vol.53 (2026)
dc.identifier.doi10.1016/j.clon.2026.104100
dc.identifier.eissn14332981
dc.identifier.issn09366555
dc.identifier.scopus2-s2.0-105034785651
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/116125
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleComment on TWO Versus Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105034785651&origin=inward
oaire.citation.titleClinical Oncology
oaire.citation.volume53
oairecerif.author.affiliationSiriraj Hospital

Files

Collections

Scopus 2026